Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 70Neoplasm Metastasis 20Rectal Neoplasms 19Colonic Neoplasms 17Neoplasms 11Cholangiocarcinoma 7Carcinoma, Non-Small-Cell Lung 7Head and Neck Neoplasms 6Esophageal Neoplasms 6Breast Neoplasms 6Carcinoma, Squamous Cell 5Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Lung Neoplasms 4Colorectal Cancer Metastatic 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Prostatic Neoplasms 3Inflammatory Breast Neoplasms 3Carcinoma 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Fallopian Tube Neoplasms 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Serotonin Syndrome 1Salivary Gland Malignancy 1

Interventions

Fluorouracil 8Bevacizumab 8Oxaliplatin 7Leucovorin 7Irinotecan 7Capecitabine 7Cetuximab 6Panitumumab 4sintilimab 2regorafenib 2aflibercept 2tremelimumab 1spartalizumab 1pembrolizumab 1irinotecan sucrosofate 1durvalumab 1camrelizumab 1atezolizumab 1anisodamine 1SHR-1701 1Radiotherapy 1Pemetrexed 1Nivolumab 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methotrexate 1Lycopene 1Loperamide 1Ipilimumab 1HMPL-013 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Cancer Metastatic × Panitumumab × Clear all
NCT06332079 2026-01-05

HAITI

Gruppo Oncologico del Nord-Ovest

Phase 2 Terminated
4 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03164655 2024-10-01

SULTAN

UNICANCER

Phase 2 Completed
20 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT04169347 2023-07-27

FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer

Criterium, Inc.

Phase 2 Unknown
27 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03751176 2021-06-30

BEYOND

Grupo Espanol Multidisciplinario del Cancer Digestivo

Phase 2 Unknown
31 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡